drugset / Trial / NCT02110966

Mepivacaine-Tramadol on the Success of Inferior Alveolar Nerve Block in Symptomatic Irreversible Pulpitis

NCT02110966

Phase 4 Completed 56 enrolled Daniel Chavarría Bolaños
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the success of inferior alveolar nerve block, after the local application of Mepivacaine plus Tramadol in patients with symptomatic irreversible pulpitis. Also, to evaluate the duration of the anesthetic effect when using Mepivacaine plus Tramadol in the same anesthetic technique and patients group. Hypothesis: Local application of mepivacaine plus tramadol increases the successful of inferior alveolar nerve block in patients with irreversible pulpitis.

Timeline

Start
2014-04
Primary completion
2014-10
Completion
2014-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tramadol Other / unclassified 0.5 ml Other
Comparator Mepivacaine Other / unclassified 1.3 ml Other
Comparator Mepivacaine Other / unclassified 1.8 ml Other

Indications